Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02138266 · ClinicalTrials.gov registry record
Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 65
- Enrollment target
NCT02138266: Completed study, sponsored by Topcon Medical Systems.
NCT02138266 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02138266 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The primary objective of this clinical study is to collect clinical data to support an FDA 510(k) submission for the Topcon Specular Microscope SP-1P. The secondary objective is to evaluate any adverse events found during the clinical study.
Interventions
- DEVICE Topcon Specular Microscope SP-1P
- DEVICE Konan Specular Microscope CELLCHEK XL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02138266
The ClinicalTrials.gov registry entry for NCT02138266 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Topcon Medical Systems, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Topcon Specular Microscope SP-1P is the first listed.
NCT02138266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02138266 about?
NCT02138266 is a clinical study titled "Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements". The primary objective of this clinical study is to collect clinical data to support an FDA 510(k) submission for the Topcon Specular Microscope SP-1P. The secondary objective is to evaluate any adverse events found during the clinical study.
What is the current status of trial NCT02138266?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2014-02. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02138266?
The interventions under investigation include: Topcon Specular Microscope SP-1P (DEVICE), Konan Specular Microscope CELLCHEK XL (DEVICE).
Who is sponsoring clinical trial NCT02138266?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.